Global Preclinical Research Outsourcing Services Market Report 2022: Rising R&D Investments and Increased Outsourcing of Non-Core Functions Drive Growth –


DUBLIN–(BUSINESS WIRE)–The “Preclinical Research Outsourcing Services: Global Markets” report has been added to from offer.

This report identifies the global preclinical research outsourcing services market, as well as all the major global preclinical CRO companies. The total preclinical research outsourcing services market is segmented globally and by geographical regions. The areas of service provided by preclinical CROs are also extensively covered.

The market for outsourcing/CRO service providers continues to show significant growth, largely attributed to increased demand for services in clinical trials, including preclinical research. The proliferation of therapies for orphan drugs and precision drugs, preclinical and clinical trials are becoming increasingly complex, driving demand for sophisticated outsourcing partners with expertise in preclinical services, disease registries, real-world evidence, medical affairs and risk-based surveillance. Expanding service offerings and capabilities remains a prominent strategy among CROs.

Outsourcing the preclinical services of the drug discovery and development process offers the pharmaceutical industry a wide range of opportunities to develop and commercialize innovative methods and technologies. Outsourcing is an attractive approach for surveys that are too complex, too expensive and too time consuming to be conducted in-house.

Previously, outsourcing was seen as a short-term strategy for demand fulfillment. From now on, it is considered as the key lever of key skills to increase the performance of pharmaceutical research. Outsourcing can have a positive impact on research performance because it reduces the cost and time associated with new innovations.

The report includes

  • An up-to-date review and analysis of the global preclinical research outsourcing services markets

  • Global market trend analyses, with historical revenue (sales) data from 2019 to 2021, estimates to 2022, and compound annual growth rate (CAGR) projections to 2026

  • Assessing and forecasting the global preclinical research outsourcing services market size, projected growth trends, and corresponding market share analysis by functional services and geographical regions

  • In-depth information (facts & figures) regarding market drivers, market disincentives, and other macroeconomic forces affecting current and future market demand

  • Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances

  • Regulatory structure of preclinical research studies in the pharmaceutical industry, marketed and pipeline products, pricing and reimbursement structure, and major developments influencing the evolution of this market

  • Detailed analysis of the strengths, weaknesses and opportunities of key players operating in the global Preclinical Research Outsourcing Services Market

  • Overview of recent industry structure, current competitive scenario, increasing investment in R&D activities, current pharma/CRO contracts and company value share analysis based on their segment revenues

There are two ways to outsource services:

  • Full vertical integration, which maximizes in-house operations.

  • Virtual Operations, which is about full outsourcing and where all operations are methodically outsourced to third parties.

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Dynamics

  • Market factors

    • Increase in R&D investments

    • Growth in outsourcing of non-core functions

    • CROS adds efficiency

  • Market constraints

    • Challenges of outsourcing preclinical research

    • Lack of qualified professionals

  • Market opportunities

    • Growing opportunities in Asia-Pacific

    • Inorganic Strategies

    • Emerging Markets

Chapter 4 Impact of Covid-19

Chapter 5 Global Market Overview

  • Overview of the preclinical process

  • Drug Substance/Active Pharmaceutical Ingredient Manufacturing Market for Drug Development

  • Manufacturers

  • Market estimation for outsourcing API manufacturing for drug development

  • Formulation and Dosage Design Outsourcing Services

  • Companies

  • Market Overview and Estimates for Formulation Development Outsourcing

  • Development, validation and testing of analytical/bioanalytical methods

  • Development of analytical methods

  • Validation, verification and qualification of analytical methods

  • Development and Validation of Analytical Testing Methods Market Landscape and Estimates

  • Companies/Suppliers

  • Outsourcing Metabolism, Pharmacokinetics and Toxicology

  • Companies/Suppliers

  • Market Estimates: Metabolism, Pharmacokinetics and Toxicology Outsourcing Services

  • Preclinical phase outsourcing services

  • Cros and outsourcing of preclinical research

  • Contract Manufacturing

  • Contract research

Chapter 6 Regulatory Landscape

Chapter 7 Market Analysis by Functional Service

  • Discovery Services

  • Chemistry

  • Bioanalysis

  • Toxicology

Chapter 8 Market Analysis by Region

Chapter 9 Competitive Landscape

  • Market share analysis

  • Current Pharma/Cro contracts

  • Mergers and Acquisitions

Chapter 10 Market Opportunity Analysis

  • Porter’s Five Forces Analysis

  • SWOT analysis

  • Highlights of the Global Preclinical Research Outsourcing Services Market

  • Challenges Within the Global Preclinical Research Outsourcing Services Market

  • Opportunities in the Global Preclinical Research Outsourcing Services Market

  • Threats to the Global Preclinical Research Outsourcing Services Market

Chapter 11 Business Profiles

  • Top 11 Cros

  • Charles River Laboratories

  • Eurofins Scientific

  • Evotec

  • Facade laboratories

  • plc icon

  • Iqvia

  • Laboratory Corporation of America Holdings

  • Medpace

  • Sg Sa

  • Thermo Fisher Scientific Inc.

  • Apptec Wuxi

For more information on this report, visit


Comments are closed.